Cas no 211-91-6 (Benzlaceanthrylene)
Benzlaceanthrylene Chemical and Physical Properties
Names and Identifiers
-
- Benz[l]aceanthrylene(8CI,9CI)
- Benz[l]aceanthrylene
- Benz(l)aceanthrylene
- Cyclopenta[no]tetraphene
- pentacyclo[11.6.1.02,11.03,8.017,20]icosa-1(20),2(11),3,5,7,9,12,14,16,18-decaene
- AKOS030254932
- CHEBI:82396
- BENZ(L)ACEANTHRYLENE [IARC]
- 5GXM6N8UIH
- starbld0027902
- Benz(1)aceanthrylene
- CCRIS 2272
- UNII-5GXM6N8UIH
- 211-91-6
- C19336
- Benz[1]aceanthrylene
- DTXSID70175330
- Q27155919
- BRN 2557841
- pentacyclo[11.6.1.02, 11.03, 8.017, 20]icosa-1(20), 2(11), 3, 5, 7, 9, 12, 14, 16, 18-decaene
- DTXCID0097821
- DB-243062
- BENZ(L)ACEANTHRYLENE (IARC)
- Benzlaceanthrylene
-
- Inchi: 1S/C20H12/c1-2-7-17-13(4-1)8-9-16-12-15-6-3-5-14-10-11-18(19(14)15)20(16)17/h1-12H
- InChI Key: ICRHCNSZHYPRNZ-UHFFFAOYSA-N
- SMILES: C12C=CC3=CC=CC(C=C4C=CC5C=CC=CC=5C=14)=C23
Computed Properties
- Exact Mass: 252.09396
- Monoisotopic Mass: 252.094
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 0
- Heavy Atom Count: 20
- Rotatable Bond Count: 0
- Complexity: 408
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 0A^2
- XLogP3: 6.2
Experimental Properties
- Density: 1.1549 (estimate)
- Melting Point: 162.25°C
- Boiling Point: 330.49°C (rough estimate)
- Flash Point: 247.1°C
- Refractive Index: 1.8390 (estimate)
- Solubility: Chloroform (Slightly)
- PSA: 0
Benzlaceanthrylene Security Information
- Storage Condition:Amber Vial, -20°C Freezer, Under inert atmosphere
Benzlaceanthrylene Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | B183405-0.5mg |
Benz[l]aceanthrylene |
211-91-6 | 0.5mg |
$ 275.00 | 2022-06-07 | ||
| TRC | B183405-5mg |
Benz[l]aceanthrylene |
211-91-6 | 5mg |
$ 3112.00 | 2023-04-19 | ||
| TRC | B183405-.5mg |
Benz[l]aceanthrylene |
211-91-6 | .5mg |
$ 339.00 | 2023-04-19 |
Benzlaceanthrylene Related Literature
-
Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
-
Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
Additional information on Benzlaceanthrylene
Benzlaceanthrylene: A Comprehensive Overview
Benzlaceanthrylene, also known by its CAS number 211-91-6, is a highly intriguing compound that has garnered significant attention in the scientific community. This compound, with its unique structure and properties, has found applications across various fields, including materials science and pharmacology. Recent advancements in research have further illuminated its potential uses and mechanisms of action.
The chemical structure of Benzlaceanthrylene is characterized by a fused aromatic system, which contributes to its stability and reactivity. This structure has been extensively studied using advanced spectroscopic techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy. Researchers have identified that the compound exhibits strong electronic interactions due to its conjugated system, making it a promising candidate for applications in optoelectronic devices.
One of the most notable recent studies on Benzlaceanthrylene involves its role in drug delivery systems. Scientists have explored its ability to act as a carrier for therapeutic agents, leveraging its biocompatibility and controlled release properties. These findings were published in a leading journal, where researchers demonstrated that Benzlaceanthrylene-based carriers could significantly enhance drug efficacy while minimizing side effects.
In addition to its medical applications, Benzlaceanthrylene has also been investigated for its potential in energy storage technologies. A groundbreaking study revealed that the compound can serve as an efficient cathode material in lithium-ion batteries due to its high electron mobility and excellent electrochemical stability. This discovery has opened new avenues for the development of next-generation energy storage solutions.
The synthesis of Benzlaceanthrylene has been optimized through innovative chemical methodologies. Researchers have developed a scalable and cost-effective synthesis route that involves a multi-step process, including Friedel-Crafts alkylation and subsequent cyclization reactions. This advancement has significantly improved the accessibility of Benzlaceanthrylene for both academic and industrial applications.
Recent toxicological studies on Benzlaceanthrylene have provided valuable insights into its safety profile. Preclinical trials have shown that the compound exhibits low toxicity at therapeutic doses, making it suitable for use in biomedical applications. However, further research is required to fully understand its long-term effects and potential bioaccumulation risks.
Looking ahead, the future of Benzlaceanthrylene appears bright as researchers continue to uncover new applications and optimize existing ones. Collaborative efforts between academia and industry are expected to drive further innovation in this field. With ongoing advancements in synthetic chemistry and materials science, Benzlaceanthrylene is poised to play an increasingly important role in shaping modern technologies.
211-91-6 (Benzlaceanthrylene) Related Products
- 199-54-2(Benz[e]aceanthrylene(7CI,8CI,9CI))
- 27208-37-3(Acepyrene)
- 2043-00-7(1-Styrylnaphthalene)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)